Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Tuberc Lung Dis ; 16(6): 774-6, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22507759

RESUMO

Despite the availability of a Mycobacterium bovis bacille Calmette Guérin (BCG) vaccine, tuberculosis (TB) remains a global public health problem. In this study, we introduced the c-di-GMP phosphodiesterase gene Rv1357c, implicated in regulating mycobacterial replication within macrophages, into BCG Pasteur, and tested the resulting strain for its capacity to serve as a vaccine against TB in a murine model. Modified BCG was more phagocytosed than its parental strain, but halted bacterial replication, and protected against M. tuberculosis challenge similarly to unmodified BCG.


Assuntos
Aciltransferases/imunologia , Vacina BCG/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose Pulmonar/prevenção & controle , Vacinação , Aciltransferases/genética , Animais , Linhagem Celular , Modelos Animais de Doenças , Macrófagos/imunologia , Macrófagos/microbiologia , Camundongos , Camundongos Endogâmicos BALB C , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/crescimento & desenvolvimento , Fagocitose , Fatores de Tempo , Tuberculose Pulmonar/imunologia , Tuberculose Pulmonar/microbiologia , Vacinas Sintéticas/imunologia
2.
Clin Vaccine Immunol ; 19(5): 797-803, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22419675

RESUMO

The mycobacterial immunodominant ESAT-6 and CFP-10 antigens are strongly recognizable in tuberculosis-infected cattle, and they do not elicit a response in cattle without infection. In addition, they are absent in most environmental mycobacterial species, and therefore, their use can be an alternative to purified protein derivative (PPD) tuberculin in the development of a more specific skin diagnostic test in cattle. The aim of the current study was to assess the potential of an ESAT-6 and CFP-10 (E6-C10) protein cocktail in a skin test format in naturally tuberculosis-infected and paratuberculosis-infected cattle. We also included MPB83 as a third component in one of the protein cocktail preparations. The protein cocktail was tested at different dose concentrations (5, 10, and 15 µg per protein). The best skin response to the E6-C10 protein cocktail was obtained with 10 µg. Subsequently, this concentration was tested in 2 herds with high and low bovine tuberculosis prevalence, the latter with paratuberculosis coinfection. Our data show that the E6-C10 cocktail allows identification of an important proportion of animals that PPDB is not able to recognize, especially in low-prevalence herds. The protein cocktail did not induce reactions in tuberculosis-free cattle or in paratuberculosis-infected cattle. Addition of MPB83 to the protein cocktail did not make any difference in the skin reaction.


Assuntos
Antígenos de Bactérias , Mycobacterium bovis/imunologia , Testes Cutâneos/métodos , Teste Tuberculínico/métodos , Tuberculose Bovina/diagnóstico , Medicina Veterinária/métodos , Animais , Proteínas de Bactérias , Bovinos , Proteínas de Membrana , Paratuberculose/diagnóstico , Projetos Piloto , Sensibilidade e Especificidade
3.
Res Vet Sci ; 90(3): 419-24, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20719347

RESUMO

The purpose was to determine IFN-g release as a response to vaccination against tuberculosis in dairy heifers under commercial settings. Four-hundred pregnant heifers from ten herds were randomly allocated into four groups: (1) unvaccinated, (2) BCG vaccinated, (3) BCG vaccinated plus a CFPP400 µg+polygen boost, and (4) BCG vaccinated plus a CFP200 µg+polygen boost, under a completely randomized blocks design. A dose of 106CFU of BCG was delivered SC in the neck, then blood samples were taken at days 0, 30, 120, 210, 300 and 720 to estimate IFN-g release in response to bovine-PPD antigen. No significant difference (P > 0.05) was observed in IFN-g release between groups at days 0 and 120. At days 30 and 210, vaccinated groups show higher IFN-g release than the control group but only difference of group 3 was significant (P < 0.05). At day 300, group 1 showed significantly higher IFN-g release. No significant difference was observed at day 720. Using IFN-g release as a surrogate for vaccine efficacy, BCG plus a boost with CFP or CFPP combined with an adjuvant that improves cellular immune response has the potential to protect cattle against tuberculosis for moderate periods of time in vaccinated cattle under commercial settings.


Assuntos
Vacina BCG/farmacocinética , Interferon gama/sangue , Tuberculose Bovina/prevenção & controle , Criação de Animais Domésticos , Animais , Vacina BCG/uso terapêutico , Bovinos/sangue , Bovinos/imunologia , Bovinos/microbiologia , Feminino , Gravidez , Tuberculose Bovina/imunologia
4.
Prev Vet Med ; 96(3-4): 161-9, 2010 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-20630607

RESUMO

Bovine tuberculosis (BTB) is a major animal health problem with zoonotic implications. Current control programs are based on test and slaughter strategies utilizing skin tests with tuberculins as antigens. The low specificity and associated operative difficulties of these tests have driven the search for new antigens and diagnostic assays. In this multicenter study, using herds from Argentina, Mexico and Northern Ireland, we selected skin test positive and negative animals from herds with different prevalence's of BTB and compared tuberculin (PPDB) and ESAT-6+CFP10 as antigens ex vivo. In low prevalence herds, crossreactivity of PPDB was apparent since up to 60% of the PPDB skin test and ex vivo positive animals did not responded to ESAT-6+CFP10 ex vivo. The superior specificity of ESAT-6+CFP10 was confirmed in a Mycobacterium avium sp. paratuberculosis infected herd where several of the animals had strong crossreactivity to PPDB and PPDA but not to ESAT-6+CFP10. In high prevalence herds 85% of the skin test-positive animals, were confirmed ex vivo using either PPDB or ESAT-6+CFP10 as antigen. However, within this group 60% of the skin test negative animals were PPDB and ESAT-6+CFP10 positive ex vivo indicating that the skin test can in some herds yield a significant number of false negative results. In conclusion, the ex vivo test is recommended as an ancillary test to accelerate BTB eradication. In high prevalence herds, PPDB or ESAT-6+CFP10 can be used as antigen whereas in low and medium prevalence herds ESAT-6+CFP10 is the preferred choice.


Assuntos
Antígenos de Bactérias , Proteínas de Bactérias , Doenças dos Bovinos/diagnóstico , Paratuberculose/diagnóstico , Tuberculose Bovina/diagnóstico , Animais , Argentina/epidemiologia , Bovinos , Doenças dos Bovinos/epidemiologia , Doenças dos Bovinos/imunologia , Reações Cruzadas , Interferon gama , México/epidemiologia , Irlanda do Norte/epidemiologia , Paratuberculose/epidemiologia , Paratuberculose/imunologia , Prevalência , Sensibilidade e Especificidade , Testes Cutâneos/veterinária , Tuberculose Bovina/epidemiologia , Tuberculose Bovina/imunologia
5.
Infect Immun ; 75(3): 1223-8, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17158896

RESUMO

Mycobacterium tuberculosis complex species survive and replicate in phagosomes of the host cell. Cell death (CD) has been highlighted as one of the probable outcomes in this host-pathogen interaction. Previously, our group demonstrated macrophage apoptosis as a consequence of Mycobacterium bovis infection. In this study, we aimed to identify the contribution of apoptotic effector elements in M. bovis-induced CD. Bovine macrophages were either infected with M. bovis (multiplicity of infection, 10:1) or treated with an M. bovis cell extract (CFE). Structural changes compatible with CD were evaluated. Chromatin condensation was increased three times by the CFE. On the other hand, a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL) assay demonstrated that levels of DNA fragmentation induced by M. bovis and CFE were 53.7% +/- 24% and 38.9% +/- 14%, respectively, whereas control cells had a basal proportion of 8.9% +/- 4.1%. Rates of DNA fragmentation were unaffected by the presence of the pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp (z-VAD). Cells treated with 100 mug of CFE for 12 h had a fivefold decrease in the level of mitochondrial outer membrane permeabilization compared to that of untreated cells. Neither M. bovis infection nor CFE treatment induced activation of caspase 3, 8, or 9. Translocation of apoptosis-inducing factor (AIF) to the nucleus was identified in 32% +/- 3.5% and 26.3% +/- 4.9% of M. bovis-infected and CFE-treated cells, respectively. Incubation of macrophages with z-VAD prior to infection did not alter the percentage of cells showing AIF translocation. Our data suggest that M. bovis-induced CD in bovine macrophages is caspase independent with AIF participation.


Assuntos
Fator de Indução de Apoptose/fisiologia , Apoptose/imunologia , Macrófagos/metabolismo , Macrófagos/patologia , Mycobacterium bovis , Animais , Caspases/fisiologia , Bovinos , Morte Celular/imunologia , Extratos Celulares , Células Cultivadas , Fragmentação do DNA , Macrófagos/enzimologia , Mycobacterium bovis/imunologia , Transporte Proteico/imunologia
6.
J Clin Microbiol ; 44(12): 4326-35, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17005738

RESUMO

Bovine tuberculosis is a major problem in many countries; hence, new and better diagnostic tools are urgently needed. In this work, we have tested ESAT6, CFP10, PE13, PE5, MPB70, TB10.4, and TB27.4 for their potentials as diagnostic markers in field animals from Northern Ireland, Mexico, and Argentina, regions with low, medium, and high prevalences of bovine tuberculosis, respectively. At all three sites, ESAT6 and CFP10 were superior diagnostic antigens, while their combination performed even better at the two sites where the combination was tested, providing the best coverage for the detection of diseased populations. The high sensitivity in the skin test reactor groups, combined with the high specificity in the tuberculosis-free groups, indicated that a diagnosis could correctly be made for 85% of the infected animals, based on their responses to these two antigens. Furthermore, TB10.4, PE13, and PE5 have the potential to supplement ESAT6 and CFP10 in a future five-component diagnostic cocktail.


Assuntos
Antígenos de Bactérias/imunologia , Técnicas Bacteriológicas , Mycobacterium bovis/imunologia , Tuberculose Bovina/diagnóstico , Animais , Argentina , Bovinos , Hipersensibilidade Tardia , Interferon gama/sangue , México , Irlanda do Norte , Proteínas Recombinantes/imunologia , Sensibilidade e Especificidade , Testes Cutâneos , Tuberculose Bovina/imunologia , Tuberculose Bovina/microbiologia
7.
Rev Latinoam Microbiol ; 42(1): 27-33, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10948826

RESUMO

The efficacy of a florfenicol premix was studied in weaning pigs experimentally inoculated with Actinobacillus pleuropneumoniae. Twenty five clinically healthy pigs were distributed into 3 groups; group A non-medicated, groups B and C orally medicated with 20 and 40 ppm of florfenicol respectively. The pigs were fed during 12 consecutive days and on day 5 all the groups were challenged with A. pleuropneumoniae serotype 1. All the animals in Group A developed clinical signs. Most of the pigs in the medicated groups maintained a good health status. Postmortem examination revealed severe pleuropneumonia in pigs from the control group and pneumonic lesions in 40% of the animals treated with 20 ppm of florfenicol. Development of pleuropneumonia was prevented in all the pigs medicated with 40 ppm of florfenicol. Actinobacillus pleuropneumoniae was recovered from the lungs of all control animals and from one pig of each of the medicated groups, however, the avidin biotin peroxidase (ABC-P) method detected the presence of the microorganism in all the animals. We demonstrated that medication with feed containing 40 ppm of florfenicol blocked efficiently the signs and lesions caused by A. pleuropneumoniae and increased the daily body weight gain.


Assuntos
Actinobacillus pleuropneumoniae/efeitos dos fármacos , Ração Animal , Antibacterianos/uso terapêutico , Aditivos Alimentares/uso terapêutico , Pleuropneumonia/veterinária , Doenças dos Suínos/prevenção & controle , Tianfenicol/análogos & derivados , Actinobacillus pleuropneumoniae/isolamento & purificação , Animais , Antibacterianos/administração & dosagem , Antibacterianos/farmacologia , Avaliação de Medicamentos/veterinária , Aditivos Alimentares/administração & dosagem , Aditivos Alimentares/farmacologia , Pulmão/microbiologia , Pulmão/patologia , Pleuropneumonia/tratamento farmacológico , Pleuropneumonia/microbiologia , Pleuropneumonia/patologia , Pleuropneumonia/prevenção & controle , Método Simples-Cego , Suínos , Doenças dos Suínos/tratamento farmacológico , Doenças dos Suínos/microbiologia , Doenças dos Suínos/patologia , Tianfenicol/administração & dosagem , Tianfenicol/farmacologia , Tianfenicol/uso terapêutico
8.
Microb Comp Genomics ; 5(3): 163-71, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11252353

RESUMO

We have determined the nucleotide sequence of a cloned DNA fragment from the human and animal pathogen Brucella melitensis. Four genes were identified from a 4069 bp fragment, corresponding to the B. melitensis a, c, b', and b subunits of the ATP synthase F0 sector operon. A duplicated and divergent copy of the b-subunit gene was observed. This feature has been found only in photosynthetic bacteria and chloroplasts. In addition, the gene cluster was separated from the F1 sector, a characteristic described only for the Rhodospirillaceae family.


Assuntos
Brucella melitensis/genética , Complexos Multienzimáticos/genética , Fosfotransferases (Aceptor do Grupo Fosfato)/genética , Rhodospirillaceae/genética , Complexos de ATP Sintetase , Sequência de Aminoácidos , Sequência de Bases , DNA Complementar/genética , Genes Bacterianos , Dados de Sequência Molecular , Família Multigênica , Óperon , Sequências Reguladoras de Ácido Nucleico , Mapeamento por Restrição , Homologia de Sequência do Ácido Nucleico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...